WEALTH ENHANCEMENT ADVISORY SERVICES, LLC
Position in ABT — Abbott Laboratories
CIK 1632972
PLYMOUTH, MN
Position in ABT
as of Mar 31, 2026
· filed Apr 8, 2026
Position Value
$123,539,628
-$70,153,449 QoQ
Shares Held
1,203,269
-22.2% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 13.79184538120736.ToString("F0")%
Shared 0.ToString("F0")%
None 86.20815461879265.ToString("F0")%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Derivatives in ABT
reported options exposure · as of Sep 30, 2024CallValue
$0
CallShares
0
PutValue
$1,276,912
PutShares
11,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Mar 31, 2026WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $292,456,726 across 40 Medical Devices names. ABT ranks #1 (42.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
This page
|
1,203,269 | $123,539,628 | |
| 2 | MDT |
Medtronic plc
|
763,139 | $66,125,994 | |
| 3 | SYK |
Stryker Corp
|
137,419 | $45,154,509 | |
| 4 | BSX |
Boston Scientific Corp
|
179,724 | $11,277,681 | |
| 5 | EW |
Edwards Lifesciences Corp
|
88,840 | $7,114,307 | |
| 6 | ZBH |
Zimmer Biomet Holdings, Inc.
|
68,719 | $6,213,571 | |
| 7 | DXCM |
Dexcom Inc
|
74,730 | $4,693,044 | |
| 8 | STE |
STERIS plc
|
19,537 | $4,320,216 |
All Filings in ABT
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $123,539,628 | 1,203,269 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $193,693,077 | 1,545,958 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $189,099,036 | 1,411,819 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $181,989,540 | 1,338,060 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $142,578,056 | 1,074,844 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $127,858,752 | 1,130,393 | Shares | Sole | 2025-03-17 | |
| 2024-09-30 | $1,276,912 | 11,200 | Put | Sole | 2024-10-24 | |
| 2024-09-30 | $119,507,562 | 1,048,220 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $124,692 | 1,200 | Put | Sole | 2024-07-16 | |
| 2024-06-30 | $107,369,163 | 1,033,290 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $45,464 | 400 | Put | Sole | 2024-04-15 | |
| 2024-03-31 | $104,664,720 | 920,858 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $1,232,784 | 11,200 | Put | Sole | 2024-01-30 | |
| 2023-12-31 | $98,822,166 | 897,812 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $94,082,317 | 971,423 | Shares | Sole | 2023-11-13 | |
| 2023-09-30 | $1,084,720 | 11,200 | Put | Sole | 2023-11-13 | |
| 2023-06-30 | $5,946,713 | 54,547 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $5,883,813 | 58,106 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $8,108,650 | 73,856 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $17,221,731 | 177,984 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $4,795,811 | 44,140 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $8,265,315 | 69,832 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $9,341,336 | 66,373 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $850,417 | 7,199 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $6,753,154 | 58,252 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $865,484 | 7,222 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $707,524 | 6,462 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $703,150 | 6,461 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $641,564 | 7,017 | Shares | Sole | 2020-10-13 | |
| 2020-03-31 | $3,314,930 | 42,009 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||